Physical activity, body fat, and serum C-reactive protein in postmenopausal women with and without hormone replacement

被引:34
作者
Manns, PJ
Williams, DP
Snow, CM
Wander, RC
机构
[1] Univ Utah, Coll Hlth, Dept Exercise & Sport Sci, Salt Lake City, UT 84112 USA
[2] Oregon State Univ, Coll Hlth & Human Performance, Dept Exercise & Sport Sci, Corvallis, OR 97331 USA
[3] Univ N Carolina, Dept Nutr & Food Serv Syst, Greensboro, NC 27412 USA
关键词
D O I
10.1002/ajhb.10117
中图分类号
Q98 [人类学];
学科分类号
030303 ;
摘要
The objective was to determine whether higher physical activity is associated with lower serum C-reactive protein (CRP), independent of oral hormone replacement therapy (HRT) status and body fatness, in 133 postmenopausal women using a cross-sectional exploratory design at a university research laboratory. The subjects were 133 postmenopausal women, age 50-73 years, with no evidence of coronary artery disease or diabetes. The main outcome measures were: serum CRP, physical activity as measured by Stanford 7-day activity recall, body fat (both total and regional) as measured by dual energy X-ray absorptiometry (DXA), and anthropometry (waist and hip circumference). Secondary outcome measures included fasting plasma glucose and insulin as well as fasting serum triglycerides, total cholesterol, high-density lipoprotein cholesterol, and low-density lipoprotein cholesterol. Higher physical activity energy expenditures were significantly associated with lower serum CRP levels (r = -0.18, P = 0.041), independent of oral HRT use, age, smoking behavior, alcohol consumption, aspirin use, and statin use. However, in the complete multivariate model, which included body fat, older ages (P = 0.047), greater trunk fat masses (P < 0.001), any oral HRT use (P < 0.001), and unopposed oral estrogen use (P = 0.012) were the sole independent predictors of higher serum CRP levels. The complete multivariate model accounted for 58% of the variance in serum CRP. We conclude that the association between higher physical activity and lower serum CRP levels is dependent on the lower body fat of the more active women, yet independent of oral HRT use. Future intervention trials should determine whether diet- and exercise-related reductions in body fat may be effective ways to diminish the proinflammatory effects of oral HRT in postmenopausal women. (C) 2002 Wiley-Liss, Inc.
引用
收藏
页码:91 / 100
页数:10
相关论文
共 46 条
  • [1] COMPENDIUM OF PHYSICAL ACTIVITIES - CLASSIFICATION OF ENERGY COSTS OF HUMAN PHYSICAL ACTIVITIES
    AINSWORTH, BE
    HASKELL, WL
    LEON, AS
    JACOBS, DR
    MONTOYE, HJ
    SALLIS, JF
    PAFFENBARGER, RS
    [J]. MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 1993, 25 (01) : 71 - 80
  • [2] ALLAIN CC, 1974, CLIN CHEM, V20, P470
  • [3] ASSMANN G, 1983, CLIN CHEM, V29, P2026
  • [4] Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss
    Bastard, JP
    Jardel, C
    Bruckert, E
    Blondy, P
    Capeau, J
    Laville, M
    Vidal, H
    Hainque, B
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (09) : 3338 - 3342
  • [5] Brett KM, 1997, AM J EPIDEMIOL, V145, P536
  • [6] High sensitivity C-reactive protein: Biological variations and reference limits
    Chenillot, O
    Henny, J
    Steinmetz, J
    Herbeth, B
    Wagner, C
    Siest, G
    [J]. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2000, 38 (10) : 1003 - 1011
  • [7] Hormone replacement therapy, inflammation, and hemostasis in elderly women
    Cushman, M
    Meilahn, EN
    Psaty, BM
    Kuller, LH
    Dobs, AS
    Tracy, RP
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (04) : 893 - 899
  • [8] Effect of postmenopausal hormones on inflammation-sensitive proteins - The Postmenopausal Estrogen/Progestin Interventions (PEPI) Study
    Cushman, M
    Legault, C
    Barrett-Connor, E
    Stefanick, ML
    Kessler, C
    Judd, HL
    Sakkinen, PA
    Tracy, RP
    [J]. CIRCULATION, 1999, 100 (07) : 717 - 722
  • [9] Effect of postmenopausal hormone therapy on body weight and waist and hip girths
    Espeland, MA
    Stefanick, ML
    KritzSilverstein, D
    Fineberg, SE
    Waclawiw, MA
    James, MK
    Greendale, GA
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (05) : 1549 - 1556
  • [10] Chronic subclinical inflammation as part of the insulin resistance syndrome -: The Insulin Resistance Atherosclerosis Study (IRAS)
    Festa, A
    D'Agostino, R
    Howard, G
    Mykkänen, L
    Tracy, RP
    Haffner, SM
    [J]. CIRCULATION, 2000, 102 (01) : 42 - 47